Research and
education
deserve attention.

Which is just
what we create.

Client's-News

22. May 2017

Working in Turbo Mode:

Not only is work life accelerating, it is also getting more intensive. A team of occupational psychologists headed by Christian Korunka has analysed this heightened pace in a project supported by the Austrian Science Fund FWF and has described the new challenges resulting from this trend. The results have recently been published in the volume "Job Demands in a Changing World of Work".

pixabay.com_PD

read more

Client's-News

17. May 2017

Taste Viennese Science! Top Tourism Region Establishes Sustainable & Regional Cuisine Based on a “Scientific Recipe” From Vienna:

Scientific expertise in the area of sustainable tourism has helped the MODUL University Vienna to secure a prestigious commission from Germany: experts from the university’s Department for Tourism and Service Management will introduce sustainable food products to hotels on the Turkish Aegean coast through a coaching and communications project.

read more

 
Latest news from Facebook Facebook

AM PULS 53 – Shoa & Nationalsozialismus: Vielen Dank an Dr. Maria Pohn-Lauggas und Dr. Helga Feldner-Busztin für die spannenden und mitreißenden Vorträge. Danke an Birgit Dalheimer für die tolle Moderation und an erinnern.at - Nationalsozialismus und Holocaust: Gedächtnis und Gegenwart für das Vermitteln einer Zeitzeugin, die die bewegte Geschichte ihrer Kindheit in der NS-Zeit als „Mischling zweiten Grades“ mit uns teilte. ... See MoreSee Less

27.02.17

View on Facebook

Dr. Helga Feldner-Busztin, eine der letzten Zeitzeuginnen des Nationalsozialismus wurde eingeladen, uns auf eine Reise der Erinnerung mitzunehmen.

Gemeinsam mit Mag. Dr. Maria Pohn-Lauggas soll außerdem diskutiert werden, wie sich der gesellschaftliche Umgang Österreichs mit der NS-Vergangenheit auf das Erinnern auswirkt.

Anmeldungen wie immer unter schnell@prd.at oder telefonisch unter 01 / 505 70 44 – Wir freuen uns auf Sie!
... See MoreSee Less

Mittwoch, 22. Februar 2017, 18:00 Uhr Getränke & Networking ab ca. 19:30 Uhr Eintritt frei! Theater Akzent Theresianumgasse 18, 1040 Wien Eine Veranstaltung des Wissenschaftsfonds (FWF) Vortragen...

AM PULS Nr. 53: Shoa & Nationalsozialismus

February 22, 2017, 6:00pm - February 22, 2017, 9:00pm

Theater Akzent

Mittwoch, 22. Februar 2017, 18:00 Uhr Getränke & Networking ab ca. 19:30 Uhr Eintritt frei! Theater Akzent Theresianumgasse 18, 1040 Wien Eine Veranstaltung des Wissenschaftsfonds (FWF) Vortragen...

25.01.17

Upcoming Events

AM PULS Nr. 54

Multiple Sclerosis

Causes,  symptoms, therapies

(in German only)

 

ap-schriftzug

Tuesday, 4 April 2017, 6 pm

More Info

Kunden-News

22. May 2017

Working in Turbo Mode:

Not only is work life accelerating, it is also getting more intensive. A team of occupational psychologists headed by Christian Korunka has analysed this heightened pace in a project supported by the Austrian Science Fund FWF and has described the new challenges resulting from this trend. The results have recently been published in the volume "Job Demands in a Changing World of Work".

pixabay.com_PD

News lesen

Kunden-News

17. May 2017

Taste Viennese Science! Top Tourism Region Establishes Sustainable & Regional Cuisine Based on a “Scientific Recipe” From Vienna:

Scientific expertise in the area of sustainable tourism has helped the MODUL University Vienna to secure a prestigious commission from Germany: experts from the university’s Department for Tourism and Service Management will introduce sustainable food products to hotels on the Turkish Aegean coast through a coaching and communications project.

News lesen

Kunden-News

15. May 2017

More than just an operation:

Losing weight by surgical intervention involves more than just shedding body fat. It is a very challenging start on a new life with a surprising number of durable positive effects. This has been shown by a study funded by the Austrian Science Fund FWF.

Suzanne Tucker_Shutterstock

News lesen

Kunden-News

12. May 2017

Marketing Approval for Children’s Cancer Immunotherapy in the EU: Outstanding Success for privately financed Austrian Biotech Company Apeiron:

On May 8, 2017, The European Commission has granted marketing authorization for "Dinutuximab beta Apeiron", an antibody-based immunotherapy of the rare pediatric cancer neuroblastoma. Thanks to the Vienna-based Biotech company Apeiron Biologics AG ("Apeiron") patients in Europe are now offered an additional treatment option with a promising therapy – a result of a collaborative effort of management and employees, academic institutions, Austrian private investors, business angels as well as public and private research initiatives.

News lesen

Kunden-News

8. May 2017

Illustrious author & statesman: Benjamin Disraeli, the celebrity:

Within the context of a FWF-funded Schrödinger Fellowship in the UK, the literary historian Sandra Mayer investigated the many facets of the best-selling author and British Prime Minister Benjamin Disraeli. Her conclusion: celebrity status is hardly any different today from what it was 150 years ago.

Benjamin_Disraeli_by_Cornelius_Jabez_Hughes,_1878

News lesen

Kunden-News

2. May 2017

The Archean ocean as an ideal breeding ground for life:

In a project funded by the Austrian Science Fund FWF, the biochemist Markus Keller demonstrated successfully how important metabolic mechanisms were able to develop in cells four billion years ago. His research provides completely new insights into the origin of life.

Brocken Inaglory, CC BY-SA 3.0

News lesen

Kunden-News

24. April 2017

The single market of interest groups:

Environmental and consumer protection have outstripped business interests in the EU. This is the conclusion drawn by an international study supported by the Austrian Science Fund FWF. The reason behind this is a wish on the part of the European institutions to widen their legitimacy.

European Parliament_Pietro Naj-Oleari

News lesen

Kunden-News

11. April 2017

Zika Virus: Themis Bioscience Initiates Worldwide First Study With Live Attenuated Recombinant Vaccine:

Vienna, Austria, 11-Apr-2017 – A promising vaccine for the Zika virus is now being tested by Themis Bioscience GmbH, a specialized biotech company developing prophylactic vaccines against emerging tropical infectious diseases. After recent progress with the development of a Chikungunya vaccine the company succeeded in swiftly adapting their proprietary vaccine technology for their Zika vaccine program. This program is based on a live attenuated recombinant vaccine that promises a fast and effective immune response.

News lesen

Kunden-News

10. April 2017

Breast milk as a weapon against cancer:

In an FWF-funded project, scientists at the University of Graz modified and reinforced a host defence peptide from breast milk so as to enable it to specifically detect cancer cells. The active substance can then induce cell death. Research continues on this new therapeutic approach to types of cancer with limited treatability.

Nor Gal_Shutterstock

News lesen